Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase EARLY_PHASE1 1

Status

Completed 5Terminated 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Focus of Study is Healthy Women at Risk for Breast Cancer 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Estrogens, Conjugated (USP) × Clear all
NCT04379024 2021-10-29

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

University of Kansas Medical Center

Phase EARLY_PHASE1 Terminated
11 enrolled
Breast

Focus of Study is Healthy Women at Risk for Breast Cancer

NCT00193726 2018-09-20

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Terminated
273 enrolled
Breast

Breast Neoplasms

NCT00002976 2013-04-11

Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

GOG Foundation

Phase 3 Terminated
2,108 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡